AlphaQuest LLC Lowers Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE)

AlphaQuest LLC cut its position in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) by 29.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,855 shares of the company’s stock after selling 765 shares during the quarter. AlphaQuest LLC’s holdings in Pulse Biosciences were worth $32,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. SG Americas Securities LLC purchased a new stake in shares of Pulse Biosciences during the fourth quarter worth about $193,000. Oppenheimer & Co. Inc. purchased a new stake in shares of Pulse Biosciences during the fourth quarter worth about $311,000. Franklin Resources Inc. purchased a new stake in shares of Pulse Biosciences during the third quarter worth about $378,000. Barclays PLC grew its holdings in shares of Pulse Biosciences by 361.4% during the third quarter. Barclays PLC now owns 30,306 shares of the company’s stock worth $530,000 after buying an additional 23,738 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Pulse Biosciences during the third quarter worth about $588,000. 76.95% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Pulse Biosciences to a “sell” rating in a report on Thursday, January 2nd.

Pulse Biosciences Stock Performance

Pulse Biosciences stock opened at $16.06 on Friday. Pulse Biosciences, Inc. has a 1 year low of $6.60 and a 1 year high of $25.00. The firm has a 50 day moving average price of $18.98 and a 200 day moving average price of $18.20.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.